(Q38190359)

30 August 2017

1 reference

title

Lymphangiogenesis and lymphatic vessel remodelling in cancer (English)

1 reference

30 August 2017

1 reference

5

1 reference

30 August 2017

Steven P Williams

2

0 references

Marc G Achen

object named as

Marc G Achen

series ordinal

6

0 references

Steven A Stacker

object named as

Steven A Stacker

series ordinal

1

0 references

Tara Karnezis

series ordinal

3

object named as

Tara Karnezis

1 reference

30 August 2017

4

Ramin Shayan

1 reference

30 August 2017

language of work or name

English

0 references

publication date

1 March 2014

1 reference

30 August 2017

published in

Nature Reviews Cancer

1 reference

30 August 2017

volume

14

1 reference

30 August 2017

issue

3

1 reference

30 August 2017

page(s)

159-172

1 reference

https://scigraph.springernature.com/pub.10.1038/nrc3677

30 August 2017

exact match

0 references

cites work

VEGF-D promotes the metastatic spread of tumor cells via the lymphatics

1 reference

Vascular endothelial growth factor-C-mediated lymphangiogenesis promotes tumour metastasis

21 January 2018

1 reference

Induction of tumor lymphangiogenesis by VEGF-C promotes breast cancer metastasis

21 January 2018

1 reference

VEGF-D promotes tumor metastasis by regulating prostaglandins produced by the collecting lymphatic endothelium

21 January 2018

1 reference

Inhibition of VEGF-C modulates distal lymphatic remodeling and secondary metastasis

21 January 2018

1 reference

VEGF-C-induced lymphangiogenesis in sentinel lymph nodes promotes tumor metastasis to distant sites

21 January 2018

1 reference

Targeting lymphangiogenesis to prevent tumour metastasis

21 January 2018

1 reference

In vivo imaging of inflammation- and tumor-induced lymph node lymphangiogenesis by immuno-positron emission tomography

21 January 2018

1 reference

Functionally specialized junctions between endothelial cells of lymphatic vessels

21 January 2018

1 reference

Transmural flow modulates cell and fluid transport functions of lymphatic endothelium

21 January 2018

1 reference

The lymphatic vasculature in disease

21 January 2018

1 reference

Lymphangiogenesis: Molecular mechanisms and future promise

21 January 2018

1 reference

Lymphatic vascular morphogenesis in development, physiology, and disease

21 January 2018

1 reference

Isolated lymphatic endothelial cells transduce growth, survival and migratory signals via the VEGF-C/D receptor VEGFR-3

21 January 2018

1 reference

Vascular endothelial growth factor and its receptor system: physiological functions in angiogenesis and pathological roles in various diseases

21 January 2018

1 reference

Functional interaction of VEGF-C and VEGF-D with neuropilin receptors

21 January 2018

1 reference

Proteolytic processing of vascular endothelial growth factor-D is essential for its capacity to promote the growth and spread of cancer

21 January 2018

1 reference

Developmental and pathological angiogenesis

21 January 2018

1 reference

VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling.

21 January 2018

1 reference

Notch restricts lymphatic vessel sprouting induced by vascular endothelial growth factor.

21 January 2018

1 reference

Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3.

21 January 2018

1 reference

Isolation and characterization of dermal lymphatic and blood endothelial cells reveal stable and functionally specialized cell lineages

21 January 2018

1 reference

Molecular characterization of lymphatic endothelial cells.

21 January 2018

1 reference

Identification of vascular lineage-specific genes by transcriptional profiling of isolated blood vascular and lymphatic endothelial cells

21 January 2018

1 reference

Transcriptomal comparison of human dermal lymphatic endothelial cells ex vivo and in vitro

21 January 2018

1 reference

Heterogeneity in immunohistochemical, genomic, and biological properties of human lymphatic endothelial cells between initial and collecting lymph vessels.

21 January 2018

1 reference

Molecular control of endothelial cell behaviour during blood vessel morphogenesis

21 January 2018

1 reference

Getting out and about: the emergence and morphogenesis of the vertebrate lymphatic vasculature.

21 January 2018

1 reference

Ccbe1 is required for embryonic lymphangiogenesis and venous sprouting

21 January 2018

1 reference

Lymphatic endothelium: an important interactive surface for malignant cells.

21 January 2018

1 reference

Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival

21 January 2018

1 reference

Tumor location and nature of lymphatic vessels are key determinants of cancer metastasis

21 January 2018

1 reference

Lymphatic vessels as targets of tumor therapy?

21 January 2018

1 reference

Imaging steps of lymphatic metastasis reveals that vascular endothelial growth factor-C increases metastasis by increasing delivery of cancer cells to lymph nodes: therapeutic implications

21 January 2018

1 reference

Vascular endothelial cell growth factor receptor 3-mediated activation of lymphatic endothelium is crucial for tumor cell entry and spread via lymphatic vessels

21 January 2018

1 reference

Proteolytic processing regulates receptor specificity and activity of VEGF-C.

21 January 2018

1 reference

The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis

21 January 2018

1 reference

Biosynthesis of vascular endothelial growth factor-D involves proteolytic processing which generates non-covalent homodimers

21 January 2018

1 reference

Multiple forms of mouse vascular endothelial growth factor-D are generated by RNA splicing and proteolysis

21 January 2018

1 reference

Plasmin activates the lymphangiogenic growth factors VEGF-C and VEGF-D

21 January 2018

1 reference

Proprotein convertases promote processing of VEGF-D, a critical step for binding the angiogenic receptor VEGFR-2

21 January 2018

1 reference

Tumor-associated macrophages express lymphatic endothelial growth factors and are related to peritumoral lymphangiogenesis

21 January 2018

1 reference

The crucial role of macrophages in lymphangiogenesis

21 January 2018

1 reference

Effective suppression of vascular network formation by combination of antibodies blocking VEGFR ligand binding and receptor dimerization

21 January 2018

1 reference

Inhibition of VEGFR-3 activation with the antagonistic antibody more potently suppresses lymph node and distant metastases than inactivation of VEGFR-2.

21 January 2018

1 reference

Suppression of tumor lymphangiogenesis and lymph node metastasis by blocking vascular endothelial growth factor receptor 3 signaling.

21 January 2018

1 reference

Inhibition of lymphogenous metastasis using adeno-associated virus-mediated gene transfer of a soluble VEGFR-3 decoy receptor

21 January 2018

1 reference

Vascular Endothelial Growth Factor Receptor 3 Is Involved in Tumor Angiogenesis and Growth

21 January 2018

1 reference

Blocking neuropilin-2 function inhibits tumor cell metastasis

21 January 2018

1 reference

Wnt1 is anti-lymphangiogenic in a melanoma mouse model

21 January 2018

1 reference

Cyclooxygenase-2 induces EP1- and HER-2/Neu-dependent vascular endothelial growth factor-C up-regulation: a novel mechanism of lymphangiogenesis in lung adenocarcinoma

21 January 2018

1 reference

COX-2-mediated stimulation of the lymphangiogenic factor VEGF-C in human breast cancer

21 January 2018

1 reference

Coexpression of VEGF-C and Cox-2 in human colorectal cancer and its association with lymph node metastasis

21 January 2018

1 reference

Host prostaglandin EP3 receptor signaling relevant to tumor-associated lymphangiogenesis

21 January 2018

1 reference

Roles of prostaglandin E2-EP3/EP4 receptor signaling in the enhancement of lymphangiogenesis during fibroblast growth factor-2-induced granulation formation.

21 January 2018

1 reference

Coexpression of VEGF-C and COX-2 and its association with lymphangiogenesis in human breast cancer

21 January 2018

1 reference

Vascular endothelial growth factor-a promotes peritumoral lymphangiogenesis and lymphatic metastasis

21 January 2018

1 reference

VEGF-A induces tumor and sentinel lymph node lymphangiogenesis and promotes lymphatic metastasis

21 January 2018

1 reference

Effects of angiopoietin-2-blocking antibody on endothelial cell-cell junctions and lung metastasis

21 January 2018

1 reference

Collaborative interplay between FGF-2 and VEGF-C promotes lymphangiogenesis and metastasis

21 January 2018

1 reference

PDGF-BB induces intratumoral lymphangiogenesis and promotes lymphatic metastasis

21 January 2018

1 reference

Hypoxia-inducible factor 1-dependent expression of platelet-derived growth factor B promotes lymphatic metastasis of hypoxic breast cancer cells

21 January 2018

1 reference

Sonic hedgehog pathway promotes metastasis and lymphangiogenesis via activation of Akt, EMT, and MMP-9 pathway in gastric cancer

21 January 2018

1 reference

Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis

21 January 2018

1 reference

Adrenomedullin gene dosage correlates with tumor and lymph node lymphangiogenesis

21 January 2018

1 reference

Sphingosine-1-phosphate produced by sphingosine kinase 1 promotes breast cancer progression by stimulating angiogenesis and lymphangiogenesis.

21 January 2018

1 reference

Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer

21 January 2018

1 reference

Inhibition of endogenous TGF-beta signaling enhances lymphangiogenesis

21 January 2018

1 reference

Integrin alpha4beta1 signaling is required for lymphangiogenesis and tumor metastasis.

21 January 2018

1 reference

Deletion of tetraspanin CD9 diminishes lymphangiogenesis in vivo and in vitro

21 January 2018

1 reference

CCR7 and its ligands: balancing immunity and tolerance

21 January 2018

1 reference

Involvement of chemokine receptors in breast cancer metastasis

21 January 2018

1 reference

Pivotal role of CXCR3 in melanoma cell metastasis to lymph nodes

21 January 2018

1 reference

Acquisition of lymph node, but not distant metastatic potentials, by the overexpression of CXCR4 in human oral squamous cell carcinoma

21 January 2018

1 reference

Dissemination of hepatocellular carcinoma is mediated via chemokine receptor CXCR4.

21 January 2018

1 reference

The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study.

21 January 2018

1 reference

Nodal lymphangiogenesis and metastasis: Role of tumor-induced lymphatic vessel activation in extramammary Paget's disease

21 January 2018

1 reference

Autologous chemotaxis as a mechanism of tumor cell homing to lymphatics via interstitial flow and autocrine CCR7 signaling

21 January 2018

1 reference

Interstitial flow in a 3D microenvironment increases glioma invasion by a CXCR4-dependent mechanism

21 January 2018

1 reference

Vascular endothelial growth factor-C and C-C chemokine receptor 7 in tumor cell-lymphatic cross-talk promote invasive phenotype

21 January 2018

1 reference

Tumor cell entry into the lymph node is controlled by CCL1 chemokine expressed by lymph node lymphatic sinuses.

21 January 2018

1 reference

Distinct vascular endothelial growth factor signals for lymphatic vessel enlargement and sprouting.

21 January 2018

1 reference

From tumor lymphangiogenesis to lymphvascular niche

21 January 2018

1 reference

Endothelial cells and VEGF in vascular development

21 January 2018

1 reference

A role for bone morphogenetic protein-4 in lymph node vascular remodeling and primary tumor growth

21 January 2018

1 reference

CXCR4 signaling regulates metastasis of chemoresistant melanoma cells by a lymphatic metastatic niche

21 January 2018

1 reference

Impaired recruitment of bone-marrow-derived endothelial and hematopoietic precursor cells blocks tumor angiogenesis and growth

21 January 2018

1 reference

VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche

21 January 2018

1 reference

Lymphatic endothelial cells - key players in regulation of tolerance and immunity

21 January 2018

1 reference

Lymphatic endothelial cells induce tolerance via PD-L1 and lack of costimulation leading to high-level PD-1 expression on CD8 T cells

21 January 2018

1 reference

Lymphatic and interstitial flow in the tumour microenvironment: linking mechanobiology with immunity

21 January 2018

1 reference

Lymphatic microvessel density and vascular endothelial growth factor-C and -D as prognostic factors in breast cancer: a systematic review and meta-analysis of the literature

21 January 2018

1 reference

Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline

21 January 2018

1 reference

Sentinel lymph node biopsy in breast cancer: a history and current clinical recommendations

21 January 2018

1 reference

Melanoma exosomes educate bone marrow progenitor cells toward a pro-metastatic phenotype through MET

21 January 2018

1 reference

Lymphangiogenesis and lymphatic metastasis in breast cancer

21 January 2018

1 reference

Focus on lymphangiogenesis in tumor metastasis.

21 January 2018

1 reference

Interaction of tumor cells and lymphatic vessels in cancer progression

21 January 2018

1 reference

Increased angiogenesis and lymphangiogenesis in inflammatory versus noninflammatory breast cancer by real-time reverse transcriptase-PCR gene expression quantification.

21 January 2018

1 reference

Absence of lymphangiogenesis and intratumoural lymph vessels in human metastatic breast cancer

21 January 2018

1 reference

Lymphatic spread of ductal pancreatic adenocarcinoma is independent of lymphangiogenesis

21 January 2018

1 reference

Lymphangiogenic growth factors as markers of tumor metastasis

21 January 2018

1 reference

Expansion of the lymphatic vasculature in cancer and inflammation: new opportunities for in vivo imaging and drug delivery.

21 January 2018

1 reference

In vivo imaging of lymph node lymphangiogenesis by immuno-positron emission tomography.

21 January 2018

1 reference

Inflammation-induced lymph node lymphangiogenesis is reversible

21 January 2018

1 reference

Signalling via vascular endothelial growth factor receptor-3 is sufficient for lymphangiogenesis in transgenic mice

21 January 2018

1 reference

Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes

21 January 2018

1 reference

Blocking VEGFR-3 suppresses angiogenic sprouting and vascular network formation

21 January 2018

1 reference

Notch signalling limits angiogenic cell behaviour in developing zebrafish arteries

21 January 2018

1 reference

Cancer dissemination--lessons from leukocytes

21 January 2018

1 reference

Signaling for lymphangiogenesis via VEGFR-3 is required for the early events of metastasis.

21 January 2018

1 reference

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

21 January 2018

1 reference

PDZ interaction site in ephrinB2 is required for the remodeling of lymphatic vasculature

21 January 2018

1 reference

Up-regulation of the lymphatic marker podoplanin, a mucin-type transmembrane glycoprotein, in human squamous cell carcinomas and germ cell tumors

21 January 2018

1 reference

The role of VEGF-C staining in predicting regional metastasis in melanoma.

21 January 2018

1 reference

Vascular endothelial growth factor-C expression correlates with lymph node localization of human melanoma metastases.

21 January 2018

1 reference

Tumor and lymph node lymphangiogenesis--impact on cancer metastasis

21 January 2018

1 reference

Lymphatic invasion is independently prognostic of metastasis in primary cutaneous melanoma

21 January 2018

1 reference

Prognostic significance of vascular endothelial cell growth factors -A, -C and -D in breast cancer and their relationship with angio- and lymphangiogenesis

21 January 2018

1 reference

Lymphangiogenesis induced by VEGF-C and VEGF-D promotes metastasis and a poor outcome in breast carcinoma: a retrospective study of 61 cases

21 January 2018

1 reference

Vascular endothelial growth factor-C and vascular endothelial growth factor-d messenger RNA expression in breast cancer: association with lymph node metastasis.

21 January 2018

1 reference

Lymphangiogenesis does not occur in breast cancer

21 January 2018

1 reference

High LYVE-1-positive lymphatic vessel numbers are associated with poor outcome in breast cancer

21 January 2018

1 reference

Lymph vascular invasion in invasive mammary carcinomas identified by the endothelial lymphatic marker D2-40 is associated with other indicators of poor prognosis

21 January 2018

1 reference

VEGF-D expression correlates with colorectal cancer aggressiveness and is downregulated by cetuximab

21 January 2018

1 reference

Sialyl Lewis X expression and lymphatic microvessel density in primary tumors of node-negative colorectal cancer patients predict disease recurrence

21 January 2018

1 reference

Prognostic significance of lymphovascular invasion in sporadic colorectal cancer

21 January 2018

1 reference

Clinical significance of vascular endothelial growth factor-C and vascular endothelial growth factor receptor 3 in patients with T1 lung adenocarcinoma

21 January 2018

1 reference

Clinical significance of VEGF-C status in tumour cells and stromal macrophages in non-small cell lung cancer patients

21 January 2018

1 reference

Lymphatic vessel density in pulmonary adenocarcinoma immunohistochemically evaluated with anti-podoplanin or anti-D2-40 antibody is correlated with lymphatic invasion or lymph node metastases.

21 January 2018

1 reference

Lymphovascular invasion in non-small-cell lung cancer: implications for staging and adjuvant therapy.

21 January 2018

1 reference

Prognostic significance of lymphovascular invasion for patients with stage I non-small cell lung cancer

21 January 2018

1 reference

Vascular endothelial growth factor-C promotes alloimmunity by amplifying antigen-presenting cell maturation and lymphangiogenesis

21 January 2018

1 reference

Monoclonal antibodies to vascular endothelial growth factor-D block its interactions with both VEGF receptor-2 and VEGF receptor-3.

21 January 2018

1 reference

Inhibition of lymphatic metastasis in neuroblastoma by a novel neutralizing antibody to vascular endothelial growth factor-D.

21 January 2018

1 reference

Inhibition of lymphangiogenesis with resulting lymphedema in transgenic mice expressing soluble VEGF receptor-3.

21 January 2018

1 reference

Alternatively spliced vascular endothelial growth factor receptor-2 is an essential endogenous inhibitor of lymphatic vessel growth.

21 January 2018

1 reference

Involvement of the VEGF receptor 3 in tubular morphogenesis demonstrated with a human anti-human VEGFR-3 monoclonal antibody that antagonizes receptor activation by VEGF-C.

21 January 2018

1 reference

Experience with sorafenib in the treatment of advanced renal cell carcinoma.

21 January 2018

1 reference

Pazopanib, a new therapy for metastatic soft tissue sarcoma

21 January 2018

1 reference

Sunitinib malate for the treatment of pancreas malignancies--where does it fit?

21 January 2018

1 reference

Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3

21 January 2018

1 reference

Axitinib for the treatment of patients with advanced metastatic renal cell carcinoma (mRCC) after failure of prior systemic treatment

21 January 2018

1 reference

The development of regorafenib and its current and potential future role in cancer therapy

21 January 2018

1 reference

Synthesis and biological profile of the pan-vascular endothelial growth factor receptor/tyrosine kinase with immunoglobulin and epidermal growth factor-like homology domains 2 (VEGF-R/TIE-2) inhibitor 11-(2-methylpropyl)-12,13-dihydro-2-methyl-8-(py

21 January 2018

1 reference

The connection between lymphangiogenic signalling and prostaglandin biology: a missing link in the metastatic pathway.

21 January 2018

1 reference

Vascular endothelial growth factor D (VEGF-D) is a ligand for the tyrosine kinases VEGF receptor 2 (Flk1) and VEGF receptor 3 (Flt4)

21 January 2018

1 reference

Preparing the "soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells

21 January 2018

1 reference

A Novel Gene Expression Profile in Lymphatics Associated with Tumor Growth and Nodal Metastasis

21 January 2018

1 reference

Lymphatic metastasis in the absence of functional intratumor lymphatics

21 January 2018

1 reference

Tumor-secreted vascular endothelial growth factor-C is necessary for prostate cancer lymphangiogenesis, but lymphangiogenesis is unnecessary for lymph node metastasis

31 March 2020

1 reference

Lymphatic endothelial cells, tumor lymphangiogenesis and metastasis: New insights into intratumoral and peritumoral lymphatics

31 March 2020

1 reference

Complete and specific inhibition of adult lymphatic regeneration by a novel VEGFR-3 neutralizing antibody

31 March 2020

1 reference

Angiopoietin-1 and -2 exert antagonistic functions in tumor angiogenesis, yet both induce lymphangiogenesis

31 March 2020

1 reference

Epidermal growth factor facilitates melanoma lymph node metastasis by influencing tumor lymphangiogenesis

31 March 2020

1 reference

Chemokine-mediated migration of melanoma cells towards lymphatics--a mechanism contributing to metastasis

31 March 2020

1 reference

Chemokine receptor CXCR3 promotes colon cancer metastasis to lymph nodes

31 March 2020

1 reference

Prediction of lymph node metastasis in colorectal carcinoma by expressionof chemokine receptor CCR7

31 March 2020

1 reference

CCR7 and CXCR4 as novel biomarkers predicting axillary lymph node metastasis in T1 breast cancer

31 March 2020

1 reference

VEGF-C promotes immune tolerance in B16 melanomas and cross-presentation of tumor antigen by lymph node lymphatics

31 March 2020

1 reference

Induced lymphatic sinus hyperplasia in sentinel lymph nodes by VEGF-C as the earliest premetastatic indicator

31 March 2020

1 reference

Relation of number of positive axillary nodes to the prognosis of patients with primary breast cancer. An NSABP update

31 March 2020

1 reference

The biologic and clinical significance of lymphatic metastases in breast cancer.

31 March 2020

1 reference

Circulating tumor cell enrichment based on physical properties.

31 March 2020

1 reference

Lymphatic invasion in cutaneous melanoma is associated with sentinel lymph node metastasis

31 March 2020

1 reference

Lymphatic microvessel density as prognostic marker in colorectal cancer

31 March 2020

1 reference

Adjuvant therapy of colon cancer

31 March 2020

1 reference

Lymph vessel density correlates with nodal status, VEGF-C expression, and prognosis in breast cancer

31 March 2020

1 reference

Lymphatic and angiogenic characteristics in breast cancer: morphometric analysis and prognostic implications

31 March 2020

1 reference

Sentinel lymphadenectomy without systematic axillary dissection in breast cancer patients: predictors of non-sentinel lymph node metastasis

31 March 2020

1 reference

Significance of lymph vessel invasion identified by the endothelial lymphatic marker D2-40 in node negative breast cancer

31 March 2020

1 reference

Association between expression of vascular endothelial growth factor C, chemokine receptor CXCR4 and lymph node metastasis in colorectal cancer

31 March 2020

1 reference

Lymphatic microvessel density is an independent prognostic factor in colorectal cancer

31 March 2020

1 reference

Lymphatic vessel density at the site of deepest penetration as a predictor of lymph node metastasis in submucosal colorectal cancer

31 March 2020

1 reference

Lymphatic vessel density and its prognostic value in stage I colorectal carcinoma

31 March 2020

1 reference

Immunohistochemical assessment of lymphovascular invasion in stage I colorectal carcinoma: prognostic relevance and correlation with nodal micrometastases

31 March 2020

1 reference

Lymphangiogenesis correlates with lymph node metastasis, prognosis, and angiogenic phenotype in human non-small cell lung cancer

31 March 2020

1 reference

Prognostic value of lymphatic and blood vessel invasion in neuroendocrine tumors of the lung

31 March 2020

1 reference

The VD1 neutralizing antibody to vascular endothelial growth factor-D: binding epitope and relationship to receptor binding

31 March 2020

1 reference

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

31 March 2020

1 reference

Lymphatic microvessel density using D2-40 is associated with nodal metastasis in non-small cell lung cancer

31 March 2020

1 reference

12 December 2020

VEGF-D is an X-linked/AP-1 regulated putative onco-angiogen in human glioblastoma multiforme

1 reference

12 December 2020

Absence of functional lymphatics within a murine sarcoma: a molecular and functional evaluation

1 reference

12 December 2020

Technical advances in sentinel lymph node biopsy for breast cancer.

1 reference

12 December 2020

Circulating nucleic acids in plasma and serum (CNAPS): applications in oncology

1 reference

12 December 2020

The secretory proprotein convertases furin, PC5, and PC7 activate VEGF-C to induce tumorigenesis

1 reference

12 December 2020

Prognostic impact of lymphatic invasion of colorectal cancer: a single-center analysis of 1,616 patients over 24 years

1 reference

12 December 2020

Evaluation of prognostic value of VEGF-C and VEGF-D in breast cancer--10 years follow-up analysis

1 reference

12 December 2020

Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer

1 reference

12 December 2020

Expression of chemokine receptor CCR7 is associated with lymph node metastasis of gastric carcinoma

1 reference

12 December 2020

A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases

1 reference

12 December 2020

Expression of vascular endothelial growth factor (VEGF)-D and its receptor, VEGF receptor 3, as a prognostic factor in endometrial carcinoma

1 reference

12 December 2020

AMG-386, a selective angiopoietin-1/-2-neutralizing peptibody for the potential treatment of cancer

1 reference

12 December 2020

Differential in vivo and in vitro expression of vascular endothelial growth factor (VEGF)-C and VEGF-D in tumors and its relationship to lymphatic metastasis in immunocompetent rats.

1 reference

12 December 2020

CXCR4 expression is associated with lymph-node metastasis of oral squamous cell carcinoma

1 reference

12 December 2020

Comparison of lymphangiogenesis between primary colorectal cancer and corresponding liver metastases

1 reference

12 December 2020

Specific adhesion molecules bind anchoring filaments and endothelial cells in human skin initial lymphatics

1 reference

12 December 2020

Podoplanin, novel 43-kd membrane protein of glomerular epithelial cells, is down-regulated in puromycin nephrosis

1 reference

12 December 2020

Lymphatic microvessel density, VEGF-C, and VEGFR-3 expression in different molecular types of breast cancer.

1 reference

12 December 2020

Vascular endothelial growth factor-D expression is an independent prognostic marker for survival in colorectal carcinoma

1 reference

12 December 2020

Vascular endothelial growth factor C promotes tumor lymphangiogenesis and intralymphatic tumor growth

1 reference

12 December 2020

Identifiers

DOI

10.1038/NRC3677

1 reference

Dimensions Publication ID

30 August 2017

1019796601

0 references

1 reference